v3.26.1
Restatement of Previously Issued Financial Statements
6 Months Ended
Jun. 30, 2026
Restatement of Previously Issued Financial Statements [Abstract]  
Restatement of Previously Issued Financial Statements
(2) Restatement of Previously Issued Financial Statements
 
In connection with a nexus study conducted with an external tax advisor, the Company’s management identified errors in previously issued financial statements. Management prepared a quantitative and qualitative analysis of the errors described below, in accordance with the SEC Staff's Accounting Bulletin ("SAB") Nos. 99 Materiality and No. 108, Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements, and concluded the aggregate impact of all the errors is material to the Company's previously reported financial statements as of and for the three and six months ended June 30, 2025. As a result, the Company’s management and the Audit Committee of the Company’s Board of Directors concluded that it is appropriate to restate the Company’s previously issued unaudited condensed financial statements as of and for the three and six months ended June 30, 2025, as previously reported in its Form 10-Q.
 
The accompanying condensed financial statements as of and for the three and six months ended June 30, 2025 have been restated from amounts previously reported. The restated classification and reported values of the errors noted from the nexus study are included in the condensed financial statements herein. The Company has also restated related amounts within the accompanying footnotes to the condensed financial statements to conform to the corrected amounts in the condensed financial statements.
 
Description of Restatement Errors
 
Based on a nexus study, the Company determined that it had economic and physical nexus in state and local jurisdictions where it historically had not been collecting and remitting sales and use tax and filing income taxes. As a result, the Company concluded that it had a historical state sales and use tax liability and income tax liability related to prior periods. The Company subsequently pursued Voluntary Disclosure Agreements (“VDAs”) to address this liability and to mitigate future exposure based on counsel of its tax advisor.
 
The liability includes an estimate for each state, to account for any interest that is due on the base tax amount owed. The error resulted in an understatement of accrued expenses for state and local sales tax and income tax, including related interest in the previously issued financial statements as of and for the three and six months ended June 30, 2025. As a result of correcting this liability, selling, general and administrative expenses; income tax expense; and interest expense were increased in the affected periods. The underlying sales tax obligations are appropriately recognized and the Company is in various stages of VDA review, submission, acceptance and payment with the states impacted. The Company has subsequently engaged an independent third-party provider of automated sales tax solutions to support with compliance through continuous identification, monitoring and evaluation of our transaction activity and physical presence.
Financial Statements - Restatement Reconciliation Tables
 
In accordance with Accounting Standards Codification ("ASC") 250, Accounting Changes and Error Corrections, the Company has corrected this error by restating previously issued financial statements.
 
The following tables summarize the effect of the restatement on each financial statement line item as of the dates, and for the periods indicated. The amounts in the "As Restated" columns are the updated amounts including the impacts from the restatement. Financial statement line items and subtotals that were not impacted by the restatement adjustments have been omitted for enhanced clarity.
 
Balance Sheet – as of December 31, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Deferred tax assets, net
 $-    $58,709   $58,709 
Total assets
  26,237,315    58,709    26,296,024 
                
Accrued expenses
  2,160,366    1,907,251    4,067,617 
Total current liabilities
  13,293,479    1,907,251    15,200,730 
Deferred tax liabilities, net
  355,646    (355,646    -  
Total liabilities
  13,883,222    1,551,605    15,434,827 
                
Accumulated deficit
  (18,054,278   (1,492,896   (19,547,174
Total stockholders’ equity
 $12,354,093   $(1,492,896  $10,861,197 
 
Statement of Operations – Three Months Ended June 30, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Selling, general, and administrative expenses  $2,627,168   $129,713   $2,756,881 
Total operating expenses   4,938,272    129,713    5,067,985 
Income from operations   121,270    (129,713   (8,443
Other income, net   179,684    (25,886   153,798 
Income before income taxes   300,954    (155,599   145,355 
Provision for income taxes   (71,427   61,513    (9,914
Net income   229,527    (94,086   135,441 
                
Net income per share – Basic and diluted  $0.02    (0.01  $0.01 
Statement of Operations - Six Months Ended June 30, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Selling, general, and administrative expenses
 $5,104,119   $266,308   $5,370,427 
Total operating expenses
  9,784,317    266,308    10,050,625 
Income from operations
  146,638    (266,308   (119,670
Other income, net
  360,516    (48,852   311,664 
Income before income taxes
  507,154    (315,160   191,994 
Provision for income taxes
  (118,565   54,203    (64,362
Net income
  388,589    (260,957   127,632 
                
Net income per share – Basic and diluted
 $0.04   $(0.03  $0.01 
 
Statements of Stockholders' Equity – Three Months Ended June 30, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Balance as of April 1, 2025
              
Accumulated deficit
 $(18,913,147  $(1,152,997  $(20,066,144
Total stockholders’ equity
  11,328,093    (1,152,997   10,175,096 
                
Balance as of June 30, 2025
              
Accumulated deficit
  (18,683,620   (1,247,083   (19,930,703
Total stockholders’ equity
 $11,677,738   $(1,247,083  $10,430,655 
 
Statements of Stockholders' Equity – Six Months Ended June 30, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Balance as of January 1, 2025
              
Accumulated deficit
 $(19,072,209  $(986,126  $(20,058,335
Total stockholders’ equity
  11,141,746    (986,126   10,155,620 
                
Balance as of June 30, 2025
              
Accumulated deficit
  (18,683,620   (1,247,083   (19,930,703
Total stockholders’ equity
 $11,677,738   $(1,247,083  $10,430,655 
 
No other components of stockholders' equity, including preferred stock, common stock and additional paid-in capital, were affected by this restatement.
 
Statement of Cash Flows –Six Months Ended June 30, 2025:
 
             
    As Previously
Reported
    Adjustment     As Restated  
                
Six Months Ended June 30, 2025
              
Cash flows from operating activities:
              
Net income
 $388,589   $(260,957  $127,632 
Changes in operating assets and liabilities:
              
Accrued expenses
 $(263,634  $260,957   $(2,677
 
The restatement had no effect on the total cash flows from operations, investing activities, or financing activities of the Company.